The 32st Science Cluster conference, “Harnessing airway immunity for next-gen vaccines”, will feature world leaders exploring the latest advancements in airway immunity and innovative vaccine development.
Our conferences has no application fees – registration is free.
Please note that the Novo Nordisk Foundation Science Cluster Conferences offers exclusive opportunities to network in an intimate setting with a carefully selected, limited body of participants. Allocation of seats at this conference takes place through a selection process through which our Scientific Committee chooses the best candidates for the conference. If you get accepted for the conference, your participation (excluding travels) is covered by the Novo Nordisk Foundation. We expect all participants and speakers to actively take part in the full duration of the conference.
The call is open.
If you wish to attend our conference, you will need to apply and submit an abstract* in our application system: Oxford Abstracts
- If you have not used the system before, click REGISTER to create an account. The email you sign up with, will be the email we will send information regarding the conference to.
- You will then receive an email with which you can login.
- When you have logged in, you can apply to the conference under the name: Harnessing airway immunity for next-gen vaccines
- Please fill out applicant info and abstract.
*If you are from industry or if, for another reason, it does not make sense for you to submit an abstract, you can apply with a motivation instead. Our scientific committee will evaluate your relevance for the conference based on your motivation.
All accepted participants will be expected to present a poster at the conference.
When can I apply: The call is open
Abstract submission: The application deadline is 1 June 2025
Evaluation of incoming applications: Beginning of June
Notifications to applicants: End of June
SHORT TALKS: Some applicants will be invited to give a short talk during the conference based on their submitted abstract. Selected applicants will be notified beginning of July.
Registration fee, accommodation and local costs for all approved applicants are covered by the Novo Nordisk Foundation. Only travel expenses to and from the conference venue will be at your own expense.
For more practical details about the conferences, please click here.
Scientific Committee:
- Thor Grundtvig Theander (Chair)
- Henrik Nyhus Kløverpris
- Rasmus Skaarup Mortensen
- Teresa Lambe
- Jakob Cramer
- Kara-Lee Aves
Speakers
European Medicines Agency
Imperial College London
La Jolla Institute for Immunology
CEPI
UNSW Sydney
Harvard TH Chan School of Public Health
IAVI
University of Basel
Next Frontier Advisors
Icahn School of Medicine at Mount Sinai & Medical University of Vienna
CEPI
National Institutes of Health
University of Oxford
Stanford University
La Jolla Institute for Immunology
Leipzig University
University of Cape Town
Royal Children’s Hospital Melbourne